Loading...
Assessment of Confirmed Clinical Hypersensitivity to Rituximab in Patients Affected with B-Cell Neoplasia
Rituximab hypersensitivity reactions are rare but are one of the main causes of rituximab elimination from antilymphoma immunochemotherapy treatments. While the clinical picture may be indistinguishable from other infusion-related reactions, hypersensitivity reactions (HSR) do not disappear and inst...
Na minha lista:
| Udgivet i: | Adv Hematol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7305539/ https://ncbi.nlm.nih.gov/pubmed/32577119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/4231561 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|